Press Releases and Announcements

Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation

March 31, 2021Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation

Martin Kessler will drive company-wide transformation and lead the ongoing expansion at the U.S. site

Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

March 22, 2021Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

Highly successful strategic alliance for biopharmaceutical development and formulation

New Modalities and Biopharma Partnerships

March 11, 2021New Modalities and Biopharma Partnerships

Our Experts featured in the European Biotechnology Spring Edition.

Rentschler Biopharma honored by CMO Leadership Awards 2021

March 5, 2021Rentschler Biopharma honored by CMO Leadership Awards 2021

Rentschler Biopharma was honored by the CMO Leadership Awards 2021 in the core categories of Reliability and Compatibility.

Rentschler Biopharma entry into cell and gene therapy

February 10, 2021Rentschler Biopharma entry into cell and gene therapy

Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK

February 10, 2021Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK

New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansion

CureVac and Rentschler Biopharma Ramp up Manufacturing of COVID-19 Vaccine, CVnCoV

February 1, 2021CureVac and Rentschler Biopharma Ramp up Manufacturing of COVID-19 Vaccine, CVnCoV

Rentschler Biopharma responsible for manufacturing, downstream processing and formulation of CureVac’s CVnCoV in Laupheim, Germany

Shaping the Future of Biopharma through Next-Generation Contract Drug Manufacturing

December 15, 2020Shaping the Future of Biopharma through Next-Generation Contract Drug Manufacturing

CEO Frank Mathias’ cover feature in Pharma’s Almanac

Diana Wiedmann, new Senior Vice President Human Relations, responsible for global strategic development of human relations

December 1, 2020Diana Wiedmann, new Senior Vice President Human Relations, responsible for global strategic development of human relations

Highly qualified team of three are taking the lead at Rentschler Biopharma’s HR department

Biopharmaceuticals: Benefits for patients with autoimmune diseases

November 2, 2020Biopharmaceuticals: Benefits for patients with autoimmune diseases

Targeted therapy, smart devices and patient support programs ensure patient well-being and benefit society at large

Rentschler Biopharma and INFOMOTION develop cloud-based datacenter for flexible and highly secure access to product information
Benefits of combining bioinformatics and an algorithm- and database-driven approach for biopharmaceutical stabilization

October 22, 2020Benefits of combining bioinformatics and an algorithm- and database-driven approach for biopharmaceutical stabilization

Article on how we maximize API potential for clients via our strategic alliance with Leukocare

Entrepreneurial success driven by vision and freedom

October 19, 2020Entrepreneurial success driven by vision and freedom

An Interview about Rentschler Biopharma’s history and future

Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement

October 14, 2020Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement

Technology will be integrated into Rentschler Biopharma’s in-house process with a fast, cost-effective, and stable platform to complement existing CLD offering

Joining forces against SARS-CoV-2

October 7, 2020Joining forces against SARS-CoV-2

Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine

Sustainable value creation and a spirit of innovation

October 1, 2020Sustainable value creation and a spirit of innovation

CEO Frank Mathias featured in in this year’s Biotechnology issue of Plattform Life Sciences.

Collaboration and continuous optimization: Cornerstones of our strategy

September 30, 2020Collaboration and continuous optimization: Cornerstones of our strategy

Article on our strategic collaboration with Vetter Pharma and insights on our COVID-19 response in Pharma’s Almanac latest issue

Rentschler Biopharma optimizes time-to-market for life-saving biopharmaceuticals

August 17, 2020Rentschler Biopharma optimizes time-to-market for life-saving biopharmaceuticals

Detailed capabilities review published in the latest BPI Industry Innovators Issue

Competitive advantages of a family-owned business

July 20, 2020Competitive advantages of a family-owned business

Flexible decision-making leads to sustainable value creation

Rentschler Biopharma’s expansion plans at U.S. site driven by an innovative business model
The key to tackling drug development complexity: Collaboration.

July 6, 2020The key to tackling drug development complexity: Collaboration.

Rentschler Biopharma and Vetter team up with joint goal to simplify processes and optimize time-to-market

Medical Biotechnology in Germany 2020

July 1, 2020Medical Biotechnology in Germany 2020

The German biotech landscape holds immense potential for advanced therapy medicinal products.

Rentschler Biopharma SE appoints Alexander Dettmer as Chief Financial Officer

June 17, 2020Rentschler Biopharma SE appoints Alexander Dettmer as Chief Financial Officer

Alexander Dettmer will head the finance, supply chain management, legal and information technology functions

Extending Collaboration with Genmab to U.S. facility

May 27, 2020Extending Collaboration with Genmab to U.S. facility

Innovative agreement provides flexible model to address Genmab’s development and manufacturing needs as programs advance in development

United we are stronger

May 25, 2020United we are stronger

Cooperation in times of COVID-19 is key to weathering the crisis

Rentschler Biopharma extends its cell line development (CLD) solutions for difficult-to-express proteins

May 19, 2020Rentschler Biopharma extends its cell line development (CLD) solutions for difficult-to-express proteins

Horizon Discovery’s CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house process

The Smart Workplace at Rentschler Biopharma

May 18, 2020The Smart Workplace at Rentschler Biopharma

What are the key elements defining smart workplaces at a biopharma CDMO?

Rentschler Biopharma’s COVID-19 Response

April 27, 2020Rentschler Biopharma’s COVID-19 Response

Reliable delivery of essential therapeutics is our top priority

A vision for achieving worldwide biopharmaceutical CDMO leadership

March 16, 2020A vision for achieving worldwide biopharmaceutical CDMO leadership

CEO Frank Mathias’ article on Strategy 2025

Competitive advantages through pharmaceutical formulations

March 9, 2020Competitive advantages through pharmaceutical formulations

Pharmind article about the Industry survey that predicts increasing investment in formulation development

Securing continuous material supply for biopharmaceutical manufacturing

March 9, 2020Securing continuous material supply for biopharmaceutical manufacturing

Interview with Matthias Walter in the “Best in Procurement” Magazine

“CDMO and Innovation Center”- Ralf Otto Interview in Genetic Engineering & Biotechnology News about our smart U.S subsidiary

February 18, 2020“CDMO and Innovation Center”- Ralf Otto Interview in Genetic Engineering & Biotechnology News about our smart U.S subsidiary

The futuristic facility will focus on process innovation and the production of designer biologics

Outsourcing Services: from Gene to Patient

February 18, 2020Outsourcing Services: from Gene to Patient

CEO Frank Mathias in ChemManager Interview

Rentschler Biopharma Adds Senior Executive to Growing U.S. Team

February 13, 2020Rentschler Biopharma Adds Senior Executive to Growing U.S. Team

Grace Kim joins as Vice President Business Development – North America and APAC

Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub

November 6, 2019Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub

New 500 L bioreactor in operation mid-2020 at U.S. site
Company’s clinical and commercial manufacturing capabilities to be showcased during BIO-Europe, November 11-13 in Hamburg, Germany

Nikolaus F. Rentschler and Frank Mathias are "EY Entrepreneur of the Year"

October 28, 2019Nikolaus F. Rentschler and Frank Mathias are "EY Entrepreneur of the Year"

Rentschler Biopharma management duo received the award on October 25

Rentschler Biopharma Announces Appointment of Karen Savage to Milford Area Chamber of Commerce Board of Directors

October 10, 2019Rentschler Biopharma Announces Appointment of Karen Savage to Milford Area Chamber of Commerce Board of Directors

Vice President Milford Karen Savage joins the Board of the Milford Area Chamber of Commerce

Rentschler Biopharma is once again featured on Germany’s top-ranked employers list

October 9, 2019Rentschler Biopharma is once again featured on Germany’s top-ranked employers list

Rentschler Biopharma for the second year in a row ranks among the best employers in the biotechnology sector by "Germany's most attractive employer" of the F.A.Z.-Institute.

Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base

October 4, 2019Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base

Company also announces participation in BioJapan 2019, one of Asia’s largest partnering events for the global biotechnology industry, October 9-11, 2019 in Pacifico Yokohama

Rentschler Biopharma is finalist for "EY Entrepreneur of the Year 2019"

September 18, 2019Rentschler Biopharma is finalist for "EY Entrepreneur of the Year 2019"

Rentschler is among the 38 companies that have made it to the final round of the coveted Entrepreneur Award

Rentschler Biopharma to highlight new U.S. facility and bioprocessing expertise at Biotech Week Boston

September 4, 2019Rentschler Biopharma to highlight new U.S. facility and bioprocessing expertise at Biotech Week Boston

Major presence at BioProcess International (BPI) Conference, September 9-12 during Biotech Week Boston. Focus on Company’s manufacturing and process development innovations with potential to significantly improve timelines and efficiency

Rentschler Biopharma is part of image video “Medical Biotechnology in Germany”

August 28, 2019Rentschler Biopharma is part of image video “Medical Biotechnology in Germany”

Germany is “the place to be” for innovative solutions and research services in the medical biotechnology field.

New Report "Medical Biotechnology in Germany 2019" published

June 26, 2019New Report "Medical Biotechnology in Germany 2019" published

Biopharmaceuticals set a new record: there were 38 approvals in 2018, as many as in the previous two years combined.

Making Downstream Processing Continuous and Robust

June 13, 2019Making Downstream Processing Continuous and Robust

Scientists of Rentschler Biopharma participated in a virtual roundtable for the Bioprocess International magazine

Interview with our CEO Dr. Frank Mathias on the expansion to USA

May 28, 2019Interview with our CEO Dr. Frank Mathias on the expansion to USA

Die Rentschler Biopharma SE sets foot in the U.S.

Driving innovation to support strategic client partnerships

May 24, 2019Driving innovation to support strategic client partnerships

New Article published by our SVP Business Development Federico Pollano

Early stage development of avanced formulations in the drug development process provides competitive advantages

March 31, 2019Early stage development of avanced formulations in the drug development process provides competitive advantages

Survey "Formulation in the Drug Product Development Process" predicts that drug product formulation recognition and budgets will increase significantly.

Rentschler Biopharma sets foot in the U.S. to strengthen its world-class CDMO position

March 13, 2019Rentschler Biopharma sets foot in the U.S. to strengthen its world-class CDMO position

An article written by our SVP Business Development Federico Pollano for the Q1 issue of pharma’s almanac

Article on smart medicine published in Plattform Life Sciences

February 28, 2019Article on smart medicine published in Plattform Life Sciences

"Chances of digitalization" by Wolfram Schulze and Tobias Rother

Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management

January 29, 2019Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management

Rentschler Biopharma SE announced today the appointment of Dr. Christian Hunzinger as the new Senior Vice President Project Management, effective from January 15, 2019.

Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site

January 3, 2019Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site

Rentschler Biopharma SE announced that the Company has completed the acquisition of a manufacturing facility from an affiliate of Shire plc.

Rentschler Biopharma SE appoints Henning Gerschewski as Vice President Manufacturing Science and Technology

December 20, 2018Rentschler Biopharma SE appoints Henning Gerschewski as Vice President Manufacturing Science and Technology

Rentschler Biopharma SE announced that Henning Gerschewski will join the company as Vice President Manufacturing Science and Technology, effective January 01, 2019.

Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc

December 17, 2018Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc

Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc

Rentschler Biopharma SE appoints Biopharmaceutical Development Expert Dr. Jesús Zurdo as Senior Vice President Process Science and Innovation

December 13, 2018Rentschler Biopharma SE appoints Biopharmaceutical Development Expert Dr. Jesús Zurdo as Senior Vice President Process Science and Innovation

Rentschler Biopharma SE announced that Dr. Jesús Zurdo will join the company as SVP Process Science and Innovation, effective January 01, 2019.

Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly

November 6, 2018Informa 2018 Survey predicts Drug Product Formulation Recognition and Budgets to increase significantly

Rentschler Biopharma SE and LEUKOCARE AG reported results from their joint publication of the 2018 Survey ‘Formulation in the Drug Product Development Process’, based on research from Informa Pharma Intelligence.

Interview with Michael Scholl of Leukocare

October 24, 2018Interview with Michael Scholl of Leukocare

"Formulation matters"

Rentschler Biopharma and LEUKOCARE to announce findings of international Drug Product Formulation Survey at BIO-Europe 2018

October 18, 2018Rentschler Biopharma and LEUKOCARE to announce findings of international Drug Product Formulation Survey at BIO-Europe 2018

The survey provides latest insights into the status quo and future of drug product formulation and its potential to refine all steps in the biopharmaceutical value chain.

Exciting lectures and stimulating exchange at the 5th Laupheim Biotech Days

September 25, 2018Exciting lectures and stimulating exchange at the 5th Laupheim Biotech Days

The 5th Laupheim Biotech Days, a bi-annual, two-day event organized by Rentschler Biopharma, took place in Laupheim, Germany on September 20th and 21st, 2018.

2017 was another record year for medical biotechnology in Germany

September 14, 20182017 was another record year for medical biotechnology in Germany

The latest biotech report from vfa bio and the Boston Consulting Group on the state of medical biotechnology in Germany is now available

Interview with Dr. Frank Mathias, CEO, Dr. Ralf Otto, COO, and Federico Pollano, SVP Business Development, in European Business Magazine
Interview with our Federico Pollano

August 31, 2018Interview with our Federico Pollano

Combining established and novel technologies

Interview in CHEManager with Dr. Frank Mathias, CEO of Rentschler Biopharma

August 15, 2018Interview in CHEManager with Dr. Frank Mathias, CEO of Rentschler Biopharma

Quality from Upper Swabia - claiming technology leadership in the pharmaceutical business

Article in European Biotechnology Magazine Summer 2018 „Combining established and novel technologies”

June 28, 2018Article in European Biotechnology Magazine Summer 2018 „Combining established and novel technologies”

An interview with Federico Pollano, SVP Business Development

Article published in the Pharma’s Almanac, June 7, 2018

June 22, 2018Article published in the Pharma’s Almanac, June 7, 2018

“Biopharma CDMO success requires technical leadership and problem-solving capabilities”
by Federico Pollano, Senior Vice President Business Development, Rentschler Biopharma SE

Article in Journal of Biotechnology, May 2, 2018

June 1, 2018Article in Journal of Biotechnology, May 2, 2018

“Multiple functions of caprylic acid-induced impurity precipitation for process intensification in monoclonal antibody purification”
by Anja Trapp, Alexander Faude, Natalie Hörold, Sven Schubert, Sabine Faust, Thilo Grob, Stefan Schmidt

Customer focus as a growth strategy

May 18, 2018Customer focus as a growth strategy

Interview with Federico Pollano in the special issue of the transkript to BIO 2018

How Rentschler Biopharma is facing the future

May 11, 2018How Rentschler Biopharma is facing the future

Presentation of Rentschler Biopharma's "Strategy 2025" at the Swiss Biotech Day 2018

Impressions from the Deutschen Biotechnologietage 2018 in Berlin

April 26, 2018Impressions from the Deutschen Biotechnologietage 2018 in Berlin

With a record attendance of more than 1000 participants, the 9th German Biotechnology Days took place in Berlin on April, 18th and 19th 2018.

Rentschler Biopharma is preparing for the future

April 25, 2018Rentschler Biopharma is preparing for the future

Rentschler Biopharma's CEO is presenting at the Swiss Biotech Day 2018

Think Big at the “Deutsche Biotechnologietage 2018” in Berlin

April 13, 2018Think Big at the “Deutsche Biotechnologietage 2018” in Berlin

Focus on Biotech in Germany

Impressions from the BIO-Europe Spring in Amsterdam

April 5, 2018Impressions from the BIO-Europe Spring in Amsterdam

Together with our strategic partners Leukocare AG and Rentschler Fill Solutions, we are looking back on very successful days at BIO-Europe Spring from March 12 to 14, 2018 in Amsterdam.

Our latest publication on Bioprocess Online, February 23, 2018

April 3, 2018Our latest publication on Bioprocess Online, February 23, 2018

“Modular approaches for diverse molecules: reinventing smart bioprocessing”

Rentschler Biopharma SE hires Dr. Thomas Rösch as Vice President Biopharma Engineering & Technology

March 28, 2018Rentschler Biopharma SE hires Dr. Thomas Rösch as Vice President Biopharma Engineering & Technology

Rentschler Biopharma SE announced that Dr. Thomas Rösch will join the Company as Vice President Biopharma Engineering & Technology, effective April 1, 2018.

Publication in Pharm. Ind. 80, No. 2 (2018)

March 26, 2018Publication in Pharm. Ind. 80, No. 2 (2018)

“Biopharmaceutical manufacturing in single-use bioreactors” by Tina Lütke-Eversloh and Peter Rogge

Join Rentschler Biopharma at the BPI West 2018

March 16, 2018Join Rentschler Biopharma at the BPI West 2018

We kindly invite you to meet us at this year’s BioProcess International West conference in San Francisco, CA from March, 19th to 22nd 2018.

A streamlined mAb platform process will be presented at the Bioprocessing Summit Europe 2018

March 15, 2018A streamlined mAb platform process will be presented at the Bioprocessing Summit Europe 2018

Integration of single-use adsorptive filtration as a unit operation for virus clearance

“Transkript persönlich” presents Dr. Ralf Otto

March 13, 2018“Transkript persönlich” presents Dr. Ralf Otto

In the March issue of the German magazine Transkript, Dr. Ralf Otto, the new COO of Rentschler Biopharma SE, gives a short insight into his life in- and outside of his office.

Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation

March 9, 2018Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation

First year of alliance delivers project wins – including four with US-based clients – proving effectiveness of new strategy

Meet Rentschler Biopharma at the BIO-Europe Spring in Amsterdam

March 8, 2018Meet Rentschler Biopharma at the BIO-Europe Spring in Amsterdam

We warmly invite you to meet us at the BIO-Europe Spring in the RAI Convention Center in Amsterdam from the 12th to 14th of March.

Rentschler Biopharma SE appoints Federico Pollano as Senior Vice President, Business Development

February 28, 2018Rentschler Biopharma SE appoints Federico Pollano as Senior Vice President, Business Development

Rentschler Biopharma SE announced that Federico Pollano has joined the Company as Senior Vice President, Business Development, effective March 1, 2018.

Rentschler Biopharma SE appoints international biopharma expert Dr. Ralf Otto as Chief Operating Officer

January 31, 2018Rentschler Biopharma SE appoints international biopharma expert Dr. Ralf Otto as Chief Operating Officer

Rentschler Biopharma SE appointed Dr. Ralf Otto as Chief Operating Officer (COO), effective February 1, 2018.

Presentation about design, structure, and manufacturability of fusion proteins at PepTalk 2018

January 29, 2018Presentation about design, structure, and manufacturability of fusion proteins at PepTalk 2018

Improved manufacturability of designed proteins

Article in Laborwelt 2017

January 18, 2018Article in Laborwelt 2017

“Expensive affinity purification”

Presentation about smart bioprocessing strategies for fusion proteins at PepTalk 2018 in San Diego, CA

January 3, 2018Presentation about smart bioprocessing strategies for fusion proteins at PepTalk 2018 in San Diego, CA

“Design, structure and manufacturability: Lessons learned from fusion proteins”

Presentation of a novel approach for antibody purification at the PEGS Europe 2017

December 1, 2017Presentation of a novel approach for antibody purification at the PEGS Europe 2017

Caprylic acid-induced precipitation as beneficial tool for mAb purification design

Article in Bioprocess International Vol 15, Issue 10, November 2017

November 29, 2017Article in Bioprocess International Vol 15, Issue 10, November 2017

"Antibody–Drug Conjugates: Fast-Track Development from Gene to Product"

Rentschler Biopharma and its partners collectively presented themselves at BIO-Europe

November 13, 2017Rentschler Biopharma and its partners collectively presented themselves at BIO-Europe

Full-service at the highest quality level

Article in American Pharmaceutical Review October 2017

November 7, 2017Article in American Pharmaceutical Review October 2017

"Strategies to Predict the Developability of Biopharmaceuticals"

Rentschler Biopharma will present at the PEGS Europe Summit 2017

November 3, 2017Rentschler Biopharma will present at the PEGS Europe Summit 2017

Presenting a novel approach for antibody purification

Invitation to meet Rentschler Biopharma at BIO-Europe 2017 in Berlin

October 23, 2017Invitation to meet Rentschler Biopharma at BIO-Europe 2017 in Berlin

World-class biomanufacturing solutions and delicious fruit juices

Great interest in CDMO Services at the BioJapan 2017

October 20, 2017Great interest in CDMO Services at the BioJapan 2017

Successful conversations and speedy portraits at the Rentschler Biopharma booth

Article in European Biotechnology, Autumn 2017

October 17, 2017Article in European Biotechnology, Autumn 2017

"Advanced formulations for biopharmaceuticals"

Article in Bioprocess International Vol 15, Issue 8, Featured Report, September 2017

October 16, 2017Article in Bioprocess International Vol 15, Issue 8, Featured Report, September 2017

“Controlling Glycosylation in Fusion Protein Manufacturing to Generate Potent Biobetters”

Participation at two European Biotech events

October 6, 2017Participation at two European Biotech events

Next-generation technologies and products

Rentschler Biotechnologie GmbH announces transition into a European corporation called Rentschler Biopharma SE

October 4, 2017Rentschler Biotechnologie GmbH announces transition into a European corporation called Rentschler Biopharma SE

Rentschler Biotechnologie GmbH has successfully transitioned into a European corporation (SE) on October 1, 2017. The Company is operating as Rentschler Biopharma SE with immediate effect.

Meet Rentschler Biopharma at BioJapan 2017

October 2, 2017Meet Rentschler Biopharma at BioJapan 2017

Receive a personal portrait by our caricaturist

Invitation to meet Rentschler at BioProcess International 2017

September 14, 2017Invitation to meet Rentschler at BioProcess International 2017

Rentschler is pleased to announce its participation in the BioProcess International Conference and Exhibition, taking place from September 25 - 28, 2017 at the Hynes Convention Center in Boston, MA.

CDMOs are champions for customization of single-use equipment

September 6, 2017CDMOs are champions for customization of single-use equipment

Inspiring presentation at The Bioprocessing Summit in Boston, MA

Scientific Formulation Seminar & Workshop at the IZB in Martinsried

September 4, 2017Scientific Formulation Seminar & Workshop at the IZB in Martinsried

Advantages of the strategic alliance of Rentschler and Leukocare will be presented

Presenting experience with single-use systems at the BioProcessing Summit in Boston, MA

August 18, 2017Presenting experience with single-use systems at the BioProcessing Summit in Boston, MA

Lecture on “Disposables in bioprocessing: Catalogue or customization?”

Minister for Economic Affairs of Baden-Württemberg visits Rentschler

August 14, 2017Minister for Economic Affairs of Baden-Württemberg visits Rentschler

In the beginning of August, Rentschler hosted a meeting with Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labour and Housing of Baden-Württemberg

Rentschler is growing continuously

August 7, 2017Rentschler is growing continuously

Growth is driven by the international market

Participation at the Annual Meeting on Continuous Biomanufacturing in Oxford, UK

July 10, 2017Participation at the Annual Meeting on Continuous Biomanufacturing in Oxford, UK

Presentation about single-use trends in development and manufacturing

Intensive networking at the top event of the biotechnology industry

June 30, 2017Intensive networking at the top event of the biotechnology industry

Rentschler presented itself at the BIO International Convention 2017

Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities

June 13, 2017Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities

Rentschler Biotechnologie GmbH and Rentschler Fill Solutions GmbH announced a strategic partnership

Participation at the BIO International Convention in San Diego, CA, USA

June 6, 2017Participation at the BIO International Convention in San Diego, CA, USA

Invitation to visit the Rentschler booth No 1929

A keen interest in current trends in cell culture at the 25th ESACT meeting in Lausanne

May 29, 2017A keen interest in current trends in cell culture at the 25th ESACT meeting in Lausanne

From May 14 to 17, 2017 more than 1,000 participants met for the 25th meeting of the European Society for Animal Cell Technology (ESACT) in Lausanne, Switzerland

Invitation to attend Rentschler’s presentations at the 25th ESACT meeting in Lausanne

May 8, 2017Invitation to attend Rentschler’s presentations at the 25th ESACT meeting in Lausanne

The 25th Meeting of the European Society for Animal Cell Technology (ESACT) will be held from 14th to 17th May 2017 in Swisstech Convention Center, Lausanne, Switzerland

Participation at 13th Annual PEGS Boston Summit 2017

May 5, 2017Participation at 13th Annual PEGS Boston Summit 2017

Presentation on fusion protein approaches to generate biobetter drugs

Rentschler/Leukocare alliance as main topic at the BIO-Europe Spring

April 3, 2017Rentschler/Leukocare alliance as main topic at the BIO-Europe Spring

Exhibition booth at BIO-Europe Spring in Barcelona, Spain

Article in European Biopharmaceutical Review April 2017

March 27, 2017Article in European Biopharmaceutical Review April 2017

“Seize the Market”

Article in Bioprocess International. Vol 15, Issue 3, March 2017

March 22, 2017Article in Bioprocess International. Vol 15, Issue 3, March 2017

“Drivers, Opportunities, and Limits of Continuous Processing”

Participation at the Bio-Europe Spring in Barcelona, Spain

March 16, 2017Participation at the Bio-Europe Spring in Barcelona, Spain

Invitation to visit the Rentschler booth No 55.

Rentschler and Leukocare announce strategic alliance and equity investment

February 2, 2017Rentschler and Leukocare announce strategic alliance and equity investment

Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried today announced a strategic alliance.

Article in Bioprocess International 14 January 2017 Featured Report

January 31, 2017Article in Bioprocess International 14 January 2017 Featured Report

"Single-Use Depth Filters - Application in Clarifying Industrial Cell Cultures"

Article in American Pharmaceutical Review. Vol 20, Issue 1, Jan/Feb 2017

January 24, 2017Article in American Pharmaceutical Review. Vol 20, Issue 1, Jan/Feb 2017

“Production Challenges for Complex Biologics: Fusion Proteins”

Rentschler well-represented at PepTalk 2017

January 16, 2017Rentschler well-represented at PepTalk 2017

Expertise in innovative protein formats highlighted in three presentations

Invitation to talk business and enjoy fruit smoothies at Bio-Europe 2016

November 18, 2016Invitation to talk business and enjoy fruit smoothies at Bio-Europe 2016

Rentschler joined the leading European biotech business conference

Rentschler attended the largest European protein and antibody engineering conference
Rentschler expands cGMP manufacturing capacity following increased international demand

November 4, 2016Rentschler expands cGMP manufacturing capacity following increased international demand

Second 2,000 liter single-use bioreactor put into operation. Further capacity expansion only a few weeks after putting into operation an innovative Twin system.

Participation at the Bio-Europe in Cologne, Germany

November 2, 2016Participation at the Bio-Europe in Cologne, Germany

Invitation to visit the Rentschler booth No 11/12

Article in World Pharma, Vol. 2, 2016

October 20, 2016Article in World Pharma, Vol. 2, 2016

"A proud history of progress through biotechnology"

Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals

September 16, 2016Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals

Innovative Twin system with two 3,000 liter bioreactors and associated downstream processing equipment put into operation. Second significant expansion in one year.

Rentschler Media Day

September 15, 2016Rentschler Media Day

Rentschler has invited to a Media Day at Laupheim

Article in American Pharmaceutical Review. Vol 19, Issue 5, Jul/Aug 2016

September 1, 2016Article in American Pharmaceutical Review. Vol 19, Issue 5, Jul/Aug 2016

"The Benefits and Limits of Disposable Technologies In Manufacturing Protein Therapeutics"

Interview with Dr. Frank Mathias and Dr. Marion Schrader in European Business
Presentation of Dr. Frank Mathias at the Biotech Press Lounge

July 14, 2016Presentation of Dr. Frank Mathias at the Biotech Press Lounge

Press Event of IZB and BioM at Martinsried near Munich

Rentschler was actively involved in top-class protein purification conference

July 11, 2016Rentschler was actively involved in top-class protein purification conference

Participation at the “Recovery XVII” in June

Rentschler again as an exhibitor at the BIO International Convention

July 6, 2016Rentschler again as an exhibitor at the BIO International Convention

Artist at the booth attracted many visitors

Successful talks of drug developers, technology providers and academia at the 4th Laupheim Biotech Days

June 17, 2016Successful talks of drug developers, technology providers and academia at the 4th Laupheim Biotech Days

Topic: Fusion Proteins - delivering novel therapeutic options

Participation at the BIO International Convention 2016 in San Francisco

June 1, 2016Participation at the BIO International Convention 2016 in San Francisco

Invitation to visit the Rentschler booth #923

Rentschler Presentations at the BPI West 2016 in Oakland, CA

April 29, 2016Rentschler Presentations at the BPI West 2016 in Oakland, CA

Rentschler’s Turbocell™ platform and single-use vs. stainless steel decision process

Participation in 15th Annual PepTalk Protein Science Week 2016

February 17, 2016Participation in 15th Annual PepTalk Protein Science Week 2016

Presentation regarding the cost constraints in therapeutic protein manufacturing

Rentschler appoints new CFO

February 15, 2016Rentschler appoints new CFO

Rentschler appoints Stefan Rampf to the position of CFO

Article in BioProcess International, Supplement Dec 2015

January 29, 2016Article in BioProcess International, Supplement Dec 2015

"The Single-Use or Stainless Steel Decision Process"

Rentschler appoints new Chief Executive Officer

January 7, 2016Rentschler appoints new Chief Executive Officer

Dr. Frank Mathias to become CEO of Rentschler Biotechnologie

Rentschler announces 4th Laupheim Biotech Days

December 15, 2015Rentschler announces 4th Laupheim Biotech Days

The biennial scientific conference is taking place from June 13 to 14, 2016

Participation in PEGS Europe 2015

November 30, 2015Participation in PEGS Europe 2015

Rentschler presented at one the most important protein therapeutics development and manufacturing meetings in Europe

Probiodrug and Rentschler sign manufacturing agreement

October 7, 2015Probiodrug and Rentschler sign manufacturing agreement

Probiodrug signs agreement with Rentschler for manufacture of its pGlu-Abeta targeting antibody PBD-C06

Article in the European Biotechnology, Autumn Edition 2015

October 2, 2015Article in the European Biotechnology, Autumn Edition 2015

"Value-adding perfusion-based biomanufacturing"

The Seventh Annual Bioprocessing Summit in Boston from 3rd to 7th August 2015

September 4, 2015The Seventh Annual Bioprocessing Summit in Boston from 3rd to 7th August 2015

Rentschler presented expertise with process platforms and modular configured processes to express and purify therapeutic Proteins

Rentschler is responsible for providing cGMP drug substance of DX-2930 for Dyax Corp.

August 12, 2015Rentschler is responsible for providing cGMP drug substance of DX-2930 for Dyax Corp.

Client News: Dyax Corp. announced today
Dyax Corp. Provides Update on DX-2930 Clinical and Commercial Supply Initiatives

Participation in PEGS Summit 2015

June 22, 2015Participation in PEGS Summit 2015

Rentschler presented at the essential protein engineering summit in Boston

Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies
Rentschler commissions new 2,000L single-use bioreactor

March 23, 2015Rentschler commissions new 2,000L single-use bioreactor

Total single-use production capacity doubled

Article in BioProcess International, Feb 2015

March 2, 2015Article in BioProcess International, Feb 2015

"Evaluating Adsorptive Filtration As a Unit Operation for Virus Removal"

Article in European Biotechnology Winter Edition 2014

January 8, 2015Article in European Biotechnology Winter Edition 2014

"Increasing manufacturability with a modular approach"

Article in Manufacturing Chemist, Oct 2014

November 26, 2014Article in Manufacturing Chemist, Oct 2014

"Employing new single-use technology in bioprocesses"

Article in European Biotechnology, Autumn Edition 2014

October 16, 2014Article in European Biotechnology, Autumn Edition 2014

"Taking mAb purification to the next level"

Rentschler presentation at The Sixth Annual Bioprocessing Summit in Boston

September 19, 2014Rentschler presentation at The Sixth Annual Bioprocessing Summit in Boston

Highlights of the latest conference in Boston

Article in transkript, Jul/Aug 2014

July 16, 2014Article in transkript, Jul/Aug 2014

"Single-Use-Bioprocesses - Hype or Future-Technology?"

Rentschler invests EUR 24 million in stainless steel bioreactor manufacturing

June 20, 2014Rentschler invests EUR 24 million in stainless steel bioreactor manufacturing

Rentschler announces the building of a Twin system with two 3,000 Liter stainless steel bioreactors mainly targeting market supply

Rentschler Expands Single-Use Manufacturing Capacities

June 10, 2014Rentschler Expands Single-Use Manufacturing Capacities

2,000 L single-use bioreactor is planned to be in operation by the beginning of 2015.

ACTIP Meeting from 12th to 13th May in Copenhagen

May 30, 2014ACTIP Meeting from 12th to 13th May in Copenhagen

Top-class exchange of experiences on the topics “Glycoengineering - Better Cells for Better Products” and “Challenges with Single Use Equipment”

Article in BioProcess International, Apr 2014

May 27, 2014Article in BioProcess International, Apr 2014

"High-Cell-Density Clarification By Single-Use Diatomaceous Earth Filtration"

Participation in Single Use Biomanufacturing III and in PEGS Summit

May 27, 2014Participation in Single Use Biomanufacturing III and in PEGS Summit

Rentschler presentations at conferences in London and Boston

Guest lectures at colleges and universities

April 15, 2014Guest lectures at colleges and universities

Rentschler promotes the education of the next generation

Presentations at Peptalk and at Cell Line Development & Engineering

March 21, 2014Presentations at Peptalk and at Cell Line Development & Engineering

Participation in international conferences and presentations of experiences and results from technology development and production.

Rentschler announces 3. Laupheimer Zelltage

March 14, 2014Rentschler announces 3. Laupheimer Zelltage

“Processes for Virus-based Biologics” is the focus of this year´s 3. Laupheimer Zelltage, which will be held from June 2-3.

Article in transkript, Mar 2014

March 10, 2014Article in transkript, Mar 2014

Platform technology and individual process, time-saving and cost-effective tachniques are required